Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

254 ARTÍCULOS , VIENDO DEL 31 AL 45

Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease

Liang Y, Xie S, He Y, Xu M, Qiao X, Zhu Y, Wu W.

Dis Markers. 2022 Jan 19;2022:9484217. doi: 10.1155/2022/9484217. eCollection 2022.

Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease

Lim YY, Maruff P, Barthélemy NR, Goate A, Hassenstab J, Sato C, Fagan AM, Benzinger TLS, Xiong C, Cruchaga C, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield PR, Morris JC, Bateman RJ, McDade E; Dominantly Inherited Alzheimer Network.

JAMA Neurol. 2022 Mar 1;79(3):261-270. doi: 10.1001/jamaneurol.2021.5181.

Challenges and hopes for Alzheimer's disease

Tatulian SA.

Drug Discov Today. 2022 Apr;27(4):1027-1043. doi: 10.1016/j.drudis.2022.01.016. Epub 2022 Feb 1.

A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach

Jutten RJ, Thompson L, Sikkes SAM, Maruff P, Molinuevo JL, Zetterberg H, Alber J, Faust D, Gauthier S, Gold M, Harrison J, Lee AKW, Snyder PJ.

J Alzheimers Dis. 2022;86(2):511-524. doi: 10.3233/JAD-215098.

Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review

van der Schaar J, Visser LNC, Bouwman FH, Ket JCF, Scheltens P, Bredenoord AL, van der Flier WM.

Alzheimers Res Ther. 2022 Feb 10;14(1):31. doi: 10.1186/s13195-022-00971-3.

Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study

Sheng C, Yang K, He B, Du W, Cai Y, Han Y.

Alzheimers Res Ther. 2022 Feb 14;14(1):35. doi: 10.1186/s13195-022-00977-x.

Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies

Verde F.

J Neural Transm (Vienna). 2022 Feb;129(2):239-259. doi: 10.1007/s00702-022-02471-y. Epub 2022 Feb 17.

Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trials

Carlson S, Kim H, Devanand DP, Goldberg TE.

Curr Opin Neurol. 2022 Apr 1;35(2):240-248. doi: 10.1097/WCO.0000000000001041.

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets

Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, Qi C, Ge J.

Biomed Pharmacother. 2022 Apr;148:112681. doi: 10.1016/j.biopha.2022.112681. Epub 2022 Feb 15.

Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium

Sexton C, Solis M, Aharon-Peretz J, Alexopoulos P, Apostolova LG, Bayen E, Birkenhager B, Cappa S, Constantinidou F, Fortea J, Gerritsen DL, Hassanin HI, Ibanez A, Ioannidis P, Karageorgiou E, Korczyn A, Leroi I, Lichtwarck B, Logroscino G, Lynch C, Mecocci P, Molinuevo JL, Papatriantafyllou J, Papegeorgiou S, Politis A, Raman R, Ritchie K, Sanchez-Juan P, Sano M, Scarmeas N, Spiru L, Stathi A, Tsolaki M, Yener G, Zaganas I, Zygouris S, Carrillo M.

Alzheimers Dement. 2022 Oct;18(10):1957-1968. doi: 10.1002/alz.12588. Epub 2022 Feb 20.

Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study

Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Baret-Rose C, Tréluyer JM, Abdoul H, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert P, Godefroy O, Camus V, Belmin J, Vandel P, Novella JL, Duron E, Rigaud AS, Schraen-Maschke S, Gabelle A; BALTAZAR study group.

Alzheimers Dement. 2022 Dec;18(12):2537-2550. doi: 10.1002/alz.12613. Epub 2022 Feb 20.

Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium

Quiroz YT, Solis M, Aranda MP, Arbaje AI, Arroyo-Miranda M, Cabrera LY, Carrasquillo MM, Corrada MM, Crivelli L, Diminich ED, Dorsman KA, Gonzales M, González HM, Gonzalez-Seda AL, Grinberg LT, Guerrero LR, Hill CV, Jimenez-Velazquez IZ, Guerra JJL, Lopera F, Maestre G, Medina LD, O'Bryant S, Peñaloza C, Pinzon MM, Mavarez RVP, Pluim CF, Raman R, Rascovsky K, Rentz DM, Reyes Y, Rosselli M, Tansey MG, Vila-Castelar C, Zuelsdorff M, Carrillo M, Sexton C.

Alzheimers Dement. 2022 Sep;18(9):1677-1686. doi: 10.1002/alz.12589. Epub 2022 Feb 24.

The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions

Murray ER, Kemp M, Nguyen TT.

Arch Clin Neuropsychol. 2022 Feb 22;37(3):595-607. doi: 10.1093/arclin/acac008.

Cerebrospinal Fluid α-Calcitonin Gene-Related Peptide: A Comparison between Alzheimer's Disease and Multiple Sclerosis

Papiri G, Vignini A, Capriotti L, Verdenelli P, Alia S, Di Paolo A, Fiori C, Baldinelli S, Silvestrini M, Luzzi S.

Biomolecules. 2022 Jan 24;12(2):199. doi: 10.3390/biom12020199.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias